| Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis SR Greisen, TK Rasmussen, K Stengaard-Pedersen, ML Hetland, ... Scandinavian journal of rheumatology 43 (2), 101-108, 2014 | 125 | 2014 |
| CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeuticwindow of opportunity' SR Greisen, KK Schelde, TK Rasmussen, TW Kragstrup, ... Arthritis research & therapy 16, 1-9, 2014 | 90 | 2014 |
| Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis SR Greisen, HJ Moller, K Stengaard-Pedersen, ML Hetland, ... Clin Exp Rheumatol 29 (4), 689-92, 2011 | 73 | 2011 |
| Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis K Aarslev, A Dige, SR Greisen, M Kreutzfeldt, N Jessen, H Vilstrup, ... Scandinavian journal of gastroenterology 52 (1), 93-99, 2017 | 52 | 2017 |
| Extracellular vesicles transfer the receptor programmed death-1 in rheumatoid arthritis SR Greisen, Y Yan, AS Hansen, MT Venø, JR Nyengaard, SK Moestrup, ... Frontiers in immunology 8, 851, 2017 | 47 | 2017 |
| The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression TW Kragstrup, SR Greisen, MA Nielsen, C Rhodes, ... Arthritis research & therapy 18, 1-12, 2016 | 41 | 2016 |
| Vitamin D increases programmed death receptor-1 expression in Crohn’s disease M Bendix, S Greisen, A Dige, CL Hvas, N Bak, SP Jørgensen, ... Oncotarget 8 (15), 24177, 2017 | 34 | 2017 |
| Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, I Adejoorin, ... Science immunology 8 (85), eadd1591, 2023 | 32 | 2023 |
| Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs SR Greisen, HJ Møller, K Stengaard-Pedersen, ML Hetland, ... Clin Exp Rheumatol 33 (4), 498-502, 2015 | 31 | 2015 |
| Spontaneous generation of functional osteoclasts from synovial fluid mononuclear cells as a model of inflammatory osteoclastogenesis SR Greisen, HB Einarsson, M Hvid, EM Hauge, B Deleuran, TW Kragstrup Apmis 123 (9), 779-786, 2015 | 26 | 2015 |
| Co-inhibitory molecules–their role in health and autoimmunity; highlighted by immune related adverse events SR Greisen, M Aspari, B Deleuran Frontiers in immunology 13, 883733, 2022 | 20 | 2022 |
| Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity LD Heftdal, K Stengaard-Pedersen, LM Ørnbjerg, ML Hetland, ... Scandinavian Journal of Clinical and Laboratory Investigation 77 (5), 385-389, 2017 | 18 | 2017 |
| Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis MA Nielsen, D Køster, S Greisen, A Troldborg, K Stengaard-Pedersen, ... Scandinavian Journal of Rheumatology 52 (1), 33-41, 2023 | 14 | 2023 |
| The programmed death-1 pathway counter-regulates inflammation-induced osteoclast activity in clinical and experimental settings SR Greisen, TW Kragstrup, JS Thomsen, K Hørslev-Pedersen, ... Frontiers in Immunology 13, 773946, 2022 | 14 | 2022 |
| Galectin-3 decreases 4-1BBL bioactivity by crosslinking soluble and membrane expressed 4-1BB MA Nielsen, K Juul-Madsen, J Stegmayr, C Gao, AY Mehta, SR Greisen, ... Frontiers in Immunology 13, 915890, 2022 | 13 | 2022 |
| T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation C Skejoe, AS Hansen, K Stengaard-Pedersen, P Junker, ... American journal of clinical and experimental immunology 11 (3), 34, 2022 | 11 | 2022 |
| Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis LD Heftdal, AG Loft, O Hendricks, A Ashouri Christiansen, ... Scandinavian journal of clinical and laboratory investigation 78 (6), 483-489, 2018 | 11 | 2018 |
| Galectin‐3 interacts with PD‐1 and counteracts the PD‐1 pathway‐driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis K Pedersen, MA Nielsen, K Juul‐Madsen, M Hvid, B Deleuran, ... Scandinavian Journal of Immunology 97 (2), e13245, 2023 | 9 | 2023 |
| Checkpoint molecules in rheumatology—or the benefits of being exhausted SR Greisen, B Deleuran Current Rheumatology Reports 23, 1-9, 2021 | 9 | 2021 |
| Programmed death ligand 2–A link between inflammation and bone loss in rheumatoid arthritis SR Greisen, TW Kragstrup, JS Thomsen, AS Hansen, A Krishnamurthy, ... Journal of translational autoimmunity 3, 100028, 2020 | 9 | 2020 |
